News

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.